Single-Strain Probiotic Lactobacilli for the Treatment of Atopic Dermatitis in Children: A Systematic Review and

Sabina Fijan1, Nina Kolč2, Metka Hrašovec2

  • 1Faculty of Health Sciences, University of Maribor, Žitna ulica 15, 2000 Maribor, Slovenia.

Pharmaceutics
|April 28, 2023
PubMed

Insights

Single-strain probiotic lactobacilli significantly reduced atopic dermatitis severity in children. Specific strains like Limosilactobacillus fermentum, longer treatment durations, and younger patient ages improved outcomes, highlighting the importance of tailored probiotic selection.

Area of Science:

  • Microbiology and Immunology
  • Pediatric Dermatology

Background:

  • Probiotics influence gut microbiota and immune system development.
  • Infant gut and skin colonization may impact atopic dermatitis (AD) risk.
  • Evidence suggests probiotics could aid in AD prevention and treatment.

Purpose of the Study:

  • To systematically review and evaluate the efficacy of single-strain probiotic lactobacilli in treating childhood atopic dermatitis.
  • To identify specific probiotic strains, treatment durations, and patient ages associated with improved AD outcomes.

Main Methods:

  • Systematic review and meta-analysis of 17 randomized placebo-controlled trials.
  • Included trials focused on single-strain lactobacilli and the Scoring Atopic Dermatitis (SCORAD) index.
  • Searches conducted in major databases (PubMed, Web of Science, etc.) until October 2022; quality assessed using Joanna Briggs Institute tools.

Main Results:

  • Meta-analysis of 14 trials (1124 children) showed single-strain lactobacilli significantly reduced SCORAD index compared to placebo (MD: -4.50, p=0.003).
  • Subgroup analysis indicated Limosilactobacillus fermentum strains were more effective than L. plantarum, L. paracasei, or L. rhamnosus.
  • Longer treatment duration and younger patient age were associated with statistically significant symptom reduction.

Conclusions:

  • Certain single-strain probiotic lactobacilli demonstrate significant efficacy in reducing atopic dermatitis severity in children.
  • Strain selection (e.g., L. fermentum), treatment duration, and patient age are critical factors for optimizing probiotic therapy effectiveness.
  • Targeted probiotic interventions hold promise for managing childhood atopic dermatitis.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...